Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: weatherproof who wrote (48031)	12/10/2018 7:57:33 PM
From: jargonweary	1 Recommendation Recommended By erippetoe Read Replies (1) \| Respond to of 63285

I agree, and yet this is still a TERRIBLE headline. Not saying it is wrong or unfair...just terrible. It is fraught with negative implications and the suggestion that there is more. “FDA hits IMMU...”. “Hits” is a pretty negative verb suggesting wrongdoing and possible punitive action. “Integrity breach” ? The implications of that phrase are horrible. “Other violations”. Sounds like there is another shoe waiting to drop. I’m not saying the substance merits much concern; I really don’t know. But that corrected headline by itself is pretty bad. Happy we did so well today but I’m worried about the next couple of days. There is fodder here for the shorts.